MarketInOut Stock Screener Log In | Sign Up
 

Teva Pharmaceutical Industries Ltd ADR

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/22/2026
Teva Pharmaceutical Industries Ltd ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization39,963 mln
Float1,083 mln
Earnings Date08/05/2026

EPS

1.34
Moderate

P / E

25.43
Elevated

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.35
Borderline

1-Year Forecast

40.27
Attractive

Relative Strength

15 / 100
Significantly lagging

Business Description

Founded over a century ago in Israel, Teva is one of the world's largest pharmaceutical companies, supplying a wide range of affordable generic medicines alongside branded treatments for conditions such as multiple sclerosis, migraines, schizophrenia, and asthma. The company sells its products across the United States, Europe, and many other markets, and also manufactures the active ingredients that go into medicines, offering production services to other companies in the industry. Teva works with several external partners to expand its pipeline and bring new treatments to patients around the globe.

Key Fundamentals

EPS1.34
P/E25.43
ROE21.44
RPS14.84
ROIC11.80
ROA3.93
Interest Cover4.42
EBITDA, mln3,270
EV / EBITDA16.50
EV / EBIT23.76
Revenue, mln17,348
EV / Revenue3.11

Financial Strength

Altman Z-Score0.93
Piotroski F-Score 7 / 9
Beneish M-Score-2.35
Price to Intrinsic Value3.15
1-Year Target Price40.27
Short Ratio5.15
Short % of Float2.69

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.64% 19 / 100   
1 Month 9.16% 90 / 100   
2 Months 0.26% 47 / 100   
6 Months 39.4% 91 / 100   
1 Year 106% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us